In a report released yesterday, Michael Grondahl from Northland Securities maintained a Buy rating on Health Insurance Innovations (HIIQ), with a price target of $85. The company’s shares opened today at $34.20.
According to TipRanks.com, Grondahl is a top 100 analyst with an average return of 30.6% and a 66.9% success rate. Grondahl covers the Financial sector, focusing on stocks such as Front Yard Residential Corporation, Altisource Portfolio Solutions SA, and WisdomTree Investments.
Currently, the analyst consensus on Health Insurance Innovations is a Strong Buy with an average price target of $65.50, which is a 91.5% upside from current levels. In a report issued on February 27, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $65 price target.
See today’s analyst top recommended stocks >>
Health Insurance Innovations’ market cap is currently $415.3M and has a P/E ratio of 28.66. The company has a Price to Book ratio of 3.85.
Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HIIQ in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Health Insurance Innovations, Inc. engages in the distribtuion of individual and family health insurance plans. It offers short-term medical; accident, sickness, and hospital; ancillary; lifestyle and discount services; and dental insurance plans. The company was founded by Michael W. Kosloske in 2008 and is headquartered in Tampa, FL.
